Top Buy
Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Eli Lilly Corp. | 51 | 0 | 6 | 0 | €691.40 | €766.92 | 10.922% |
Boston Scientific | 46 | 0 | 13 | 0 | €67.50 | €72.96 | 8.084% |
Biogen Inc. | 44 | 2 | 4 | 1 | €198.25 | €293.57 | 48.082% |
Vertex Pharmaceuticals Inc. | 40 | 2 | 4 | 0 | €371.25 | €382.71 | 3.086% |
Alnylam Pharmace. | 36 | 0 | 3 | 0 | €140.00 | €228.30 | 63.071% |
Regeneron Pharmaceuticals Inc. | 34 | 1 | 7 | 1 | €869.20 | €957.22 | 10.127% |
Intuitive Surgical Inc | 34 | 0 | 4 | 0 | €352.10 | €370.00 | 5.084% |
UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €457.15 | €543.72 | 18.937% |
Johnson & Johnson | 32 | 1 | 2 | 0 | €139.70 | €196.74 | 40.827% |
Pfizer Inc. | 31 | 4 | 3 | 1 | €25.96 | €41.10 | 58.363% |
Merck & Co. Inc. | 28 | 1 | 3 | 0 | €120.00 | €124.93 | 4.108% |
Thermo Fisher Scientific Inc. | 27 | 0 | 6 | 0 | €534.50 | €568.09 | 6.285% |
Neurocrine Bioscience | 27 | 0 | 7 | 0 | €128.00 | €140.34 | 9.641% |